INTRODUCTION
============

NAD(P)H: quinone oxidoreductase 1 (NQO1), a cytosolic FAD-dependent flavoprotein, catalyzes the reduction of quinines, quinoneimines, and nitroaromatics and regulates the intracellular ratio of NAD and NADH in several cells. Human NQO1 protein is highly expressed in numerous cells including epithelial cells, vascular endothelium, and adipocyte cells, where it is localized in the cytosol and the nucleus ([@b1-bmb-49-617]--[@b4-bmb-49-617]). Several studies have demonstrated that NQO1 is a multifunctional protein, and shows an antioxidant effect by decreasing the intracellular reactive oxygen species (ROS) levels and various toxicities ([@b3-bmb-49-617], [@b4-bmb-49-617]). Other studies have shown that NQO1 protein plays a key role in various tumors, including breast, hepatoma, and pancreas, by exerting its effects on tumor growth inhibition, suggesting NQO1 protein as a potential therapeutic agent for cancer ([@b5-bmb-49-617], [@b6-bmb-49-617]). However, the protective function and precise mechanism of NQO1 protein in ischemia are still unclear.

Oxidative stress induced by reactive oxygen species (ROS) is strongly implicated in brain diseases, including ischemia. Excessive oxidative stress alters the structure of proteins, lipids, and DNA, as well as cellular homeostasis signaling pathways, finally leading to cell death ([@b7-bmb-49-617], [@b8-bmb-49-617]). Antioxidant proteins are known to play a critical role in various diseases. Recent studies have shown that ischemia reperfusion-induced oxidative stress plays an important role in the pathogenesis of cerebral ischemia, and antioxidants are in use for the treatment of ischemia ([@b9-bmb-49-617], [@b10-bmb-49-617]).

Protein transduction domains (PTDs) deliver various molecules into cells, and are widely used as therapeutic strategies for various diseases including neuronal disorders ([@b11-bmb-49-617], [@b12-bmb-49-617]). In previous studies, we have demonstrated that antioxidant PTD fusion proteins transduce into various cells, and markedly inhibit cell damage induced by oxidative stress ([@b13-bmb-49-617]--[@b17-bmb-49-617]). In this study, we investigated the effects of Tat-NQO1 protein against oxidative stress-induced HT-22 cell death, and ischemic injury in an animal model.

RESULTS AND DISCUSSION
======================

Transduction of purified Tat-NQO1 protein into HT-22 cells
----------------------------------------------------------

NQO1 protein is a multifunctional protein which plays a detoxifying role against various stimuli. Recent studies have revealed that NQO1 protein prevents acute renal damage induced by ischemia-reperfusion injury (IRI), via inhibition of renal oxidative stress ([@b18-bmb-49-617], [@b19-bmb-49-617]). Therefore, we constructed a cell permeable Tat-NQO1 protein to study whether Tat-NQO1 protein has protective effects against oxidative stress-induced hippocampal neuronal cell damage. As shown in [Fig. 1A](#f1-bmb-49-617){ref-type="fig"}, the Tat-NQO1 protein expression vector contained a NQO1 cDNA, Tat peptide, and six histidine residues at the amino-terminus. However, the control NQO1 protein expression vector contained no Tat peptides. After the Tat-NQO1 or control NQO1 proteins were overexpressed with IPTG in *E. coli*, the proteins were purified using a Ni-NTA His affinity column and PD-10 column chromatography. Purified Tat-NQO1 and control NQO1 proteins were analyzed by SDS-PAGE and Western blot analysis using an anti-histidine antibody ([Fig. 1A](#f1-bmb-49-617){ref-type="fig"}).

To determine whether Tat-NQO1 proteins transduce into HT-22 cells, the cells were treated with various quantities of Tat-NQO1 protein (0.5--3 μM) for 2 h, or with Tat-NQO1 protein (3 μM) for various times (10--120 min). The transduced proteins were then measured by Western blotting analysis. [Figs. 1B and 1C](#f1-bmb-49-617){ref-type="fig"} show that Tat-NQO1 protein transduced into the cells in dose- and time-dependent manners. However, control NQO1 protein did not transduce under the same experimental conditions. In addition, we observed that transduced Tat-NQO1 protein levels significantly persisted for up to 60 h in the cells ([Fig. 1D](#f1-bmb-49-617){ref-type="fig"}). These results indicate that constructed and purified Tat-NQO1 protein successfully transduced into HT-22 cells, where it persisted for up to 60 h.

Since protein transduction domains (PTDs) can successfully deliver numerous proteins into cells or tissues, PTD fusion proteins are commonly used to better understand the novel functions of various proteins. Many studies have demonstrated that PTD fusion proteins, including Tat peptide, can be used as therapeutic proteins in various diseases ([@b11-bmb-49-617], [@b12-bmb-49-617]--[@b17-bmb-49-617]).

Effects of transduced Tat-NQO1 protein against H~2~O~2~-induced cell death
--------------------------------------------------------------------------

We performed fluorescence analysis to examine the distribution of transduced Tat-NQO1 protein in HT-22 cells. In Tat-NQO1 protein treated cells, fluorescence signals were detected in both the nucleus and cytosol of HT-22 cells. In contrast, fluorescence signals were undetected in cells treated with control NQO1 protein ([Fig. 2A](#f2-bmb-49-617){ref-type="fig"}).

ROS are closely associated with various diseases, including ischemia. Ischemic injury induces neuronal cell death by production of excessive ROS, which leads to destruction of DNA, protein, and lipids, and ultimately cell death ([@b7-bmb-49-617], [@b20-bmb-49-617], [@b21-bmb-49-617]). To confirm whether transduced Tat-NQO1 protein has protective effects against H~2~O~2~-induced HT-22 cell death, HT-22 cells were treated with Tat-NQO1 protein (3 μM) and control NQO1 protein (3 μM) for 2 h, followed by H~2~O~2~ (1 mM) treatment for 10 h. Vehicle control group cells were treated with only H~2~O~2~ (1 mM) for 10 h. Cell survival increased up to 67% in Tat-NQO1 protein treated cells, whereas control NQO1 protein showed the same patterns as the H~2~O~2~ only treated cells ([Fig. 2B](#f2-bmb-49-617){ref-type="fig"}).

Next, using fluorescence staining, we determined the effects of Tat-NQO1 protein against H~2~O~2~-induced intracellular ROS generation and DNA fragmentation in HT-22 cells. Fluorescence signal levels were markedly increased in H~2~O~2~ exposed cells compared to control cells, and the fluorescence signals in control NQO1 protein treated cells were similar to the H~2~O~2~ exposed cells ([Fig. 2C and 2D](#f2-bmb-49-617){ref-type="fig"}). However, fluorescence signals were markedly reduced in Tat-NQO1 protein treated cells. These results indicate that transduced Tat-NQO1 protein inhibits oxidative stress-induced cell death and has as antioxidant function by reducing ROS generation and DNA damage. In agreement with our results, other studies have demonstrated that NQO1 protein plays an antioxidant protein role, inhibiting salt- or cisplatin-induced ROS production and renal damage in ACHN cells, human kidney cell line, and in a NQO1^−/−^ mice model ([@b22-bmb-49-617]--[@b24-bmb-49-617]). Another study reported that pre-treatment of β-lapachone (β-LAP), which is known as an activator of NQO1, showed increase in the NQO1 activity and inhibition of total ROS levels, H~2~O~2~, superoxide anion radical, lipid peroxidation, and DNA damage in high salt-induced kidney of rats ([@b23-bmb-49-617]). Therefore, our results are consistent with results wherein NQO1 has an anti-oxidant effect, and protects the cells and tissues against oxidative damage.

Effects of Tat-NQO1 protein on H~2~O~2~-induced activation of Akt, MAPK and caspase-3
-------------------------------------------------------------------------------------

Several studies have shown that Akt and MAPK signaling pathways are associated with ROS, get activated by oxidative stress, and eventually lead to cell death ([@b25-bmb-49-617], [@b26-bmb-49-617]). We examined the effects of Tat-NQO1 protein against H~2~O~2~-induced Akt and MAPK activation in HT-22 cells. Tat-NQO1 protein markedly reduced the activation of Akt and MAPK levels in the H~2~O~2~ exposed HT-22 cells, whereas control NQO1 protein did not demonstrate similar effects ([Fig. 3A and 3B](#f3-bmb-49-617){ref-type="fig"}). Consistent with our results, recent studies have demonstrated that β-LAP inhibited H~2~O~2~ induced ROS production and cell death in rat primary astrocytes. Also, β-LAP increased antioxidant enzyme expression in rat primary astrocytes, and enhanced the cell survival via regulation of AMPK/PI3K-Nrf2/ARE signaling as well as activation of Akt and MAPK signaling pathways ([@b27-bmb-49-617]).

It is well known that apoptotic triggers can activate the mitochondrial pathway and active caspase cascades, which in turn activate caspase-3, finally leading to cellular apoptosis. The balance of apoptosis related factors is important for cell homeostasis ([@b28-bmb-49-617], [@b29-bmb-49-617]). We examined the effects of Tat-NQO1 protein against H~2~O~2~-induced changes in caspase-3 and cleaved caspase-3 expression levels in HT-22 cells. We observed that Tat-NQO1 protein increased the caspase-3 expression levels in the H~2~O~2~ exposed HT-22 cells, whereas it had an inverse effect on the expression levels of cleaved caspase-3. Control NQO1 protein did not change the protein expression levels under the same conditions ([Fig. 3C](#f3-bmb-49-617){ref-type="fig"}). These results indicate that Tat-NQO1 protein promotes cell survival in H~2~O~2~-induced HT-22 cells via regulation of Akt and MAPK activation as well as apoptosis signaling.

Effects of Tat-NQO1 protein against ischemic insults
----------------------------------------------------

To determine the effects of transduced Tat-NQO1 protein against ischemic insults, we performed immunostaining using an anti-histidine, NeuN, and DAPI antibody. [Fig. 4A](#f4-bmb-49-617){ref-type="fig"} shows that Histidine- and NeuN-immunoreactive cells were markedly increased in the hippocampal CA1 region in the Tat-NQO1 protein treated group compared to the vehicle treated group. In contrast, the control NQO1 protein treated group showed a similar pattern to the vehicle treated group. These results indicate that Tat-NQO1 protein transduced into the hippocampal CA1 region, successfully crossing the blood-brain barrier (BBB), where it protected against hippocampal neuronal cell death resulting from ischemic insults.

We also performed cresyl violet (CV) and Fluoro-Jade B (F-JB) staining to examine hippocampal neuronal cell death resulting from ischemic insults ([Fig. 4B](#f4-bmb-49-617){ref-type="fig"}). CV-immunoreactive cells were significantly increased in the hippocampal CA1 region in the Tat-NQO1 protein treated group, whereas there was no significant differentiation of CV-immunoreactive cells in the control NQO1 protein treated group as compared to the vehicle group. In the vehicle treated group, F-JB-immunoreactive cells were increased in the CA1 region compared to that in the sham control group. However, Tat-NQO1 protein treated groups had markedly reduced F-JB-immunoreactive cells in the CA1 region compared to the vehicle treated group. Further, we performed ionized calcium-binding adapter molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP) staining to examine the effects of Tat-NQO1 protein on the activation of astrocytes and microglia in the hippocampal CA1 region. As shown in [Fig. 4B](#f4-bmb-49-617){ref-type="fig"}, Tat-NQO1 protein markedly reduced the levels of Iba-1 and GFAP-immunoreactive cells, whereas control NQO1 protein did not show the same effects. These results indicate that transduced Tat-NQO1 protein significantly protected against ischemic insults via inhibition of astrocyte and microglia activation.

The activation of astrocytes and microglia are highly associated with ischemic injury, and is increased in the hippocampus CA1 region in animal models of ischemia ([@b30-bmb-49-617], [@b31-bmb-49-617]). Several studies have demonstrated that NQO1 protein prevents acute renal damage induced by ischemia-reperfusion. Also, β-LAP prevented primary astrocyte damage caused by oxidative stress ([@b19-bmb-49-617], [@b24-bmb-49-617], [@b27-bmb-49-617]). In agreement with these results, we showed that Tat-NQO1 protein significantly inhibited the activation of astrocytes and microglia in an animal model of ischemia. However, further studies are needed to evaluate the role of Tat-NQO1 protein on ischemic injury, and clarify the precise mechanism behind this process.

To summarize, we have demonstrated that Tat-NQO1 protein are transduced into HT-22 cells, and the transduced protein significantly protected against oxidative stress-induced HT-22 cell death by inhibition of cellular toxicities and activation of Akt and MAPK. In addition, Tat-NQO1 protein exerts a protective effect against ischemic injury, suggesting that Tat-NQO1 protein may be a potential strategy for neuronal disorders, including ischemia.

MATERIALS AND METHODS
=====================

See [supplementary information](#s1-bmb-49-617){ref-type="supplementary-material"} for this section.
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![Purification and transduction of Tat-NQO1 protein into HT-22 cells. Purification of Tat-NQO1 protein. Purified proteins were analyzed by 12% SDS-PAGE and subjected to Western blot analysis with an anti-histidine antibody (A). Transduction of Tat-NQO1 proteins into HT-22 cells. Tat-NQO1 or control NQO1 (0.5--3 μM) proteins were added to the culture medium for 2 h (B), Tat-NQO1 or control NQO1 (3 μM) proteins were added to the culture medium for 10--120 min (C). Intracellular stability of transduced Tat-NQO1 protein. Cells were exposed to Tat-NQO1 (3 μM) protein for 2 h over various time periods. The levels of Tat-NQO1 protein were then measured by Western blotting. Band intensity was assessed by densitometer (D).](bmb-49-617f1){#f1-bmb-49-617}

![Effects of transduced Tat-NQO1 protein against H~2~O~2~-induced cellular toxicity. Cellular distribution of transduced Tat-NQO1 protein in HT-22 cells. Cells were treated with Tat-NQO1 (3 μM) protein for 2 h, and the cellular distribution of Tat-NQO1 proteins was observed by confocal microscopy (A). Scale bar = 20 μm. Effect of Tat-NQO1 protein against H~2~O~2~-induced cellular toxicities. Tat-NQO1 proteins were added to the culture medium, after which cells were exposed to H~2~O~2~, as described in the "Materials and methods" section. Cell viability was assessed by MTT assay (B), ROS levels were measured using DCF-DA staining (C), and DNA fragmentation was detected by TUNEL staining (D). Scale bar = 50 μm. \*\*P \< 0.01, compared with H~2~O~2~-treated cells.](bmb-49-617f2){#f2-bmb-49-617}

![Effect of Tat-NQO1 protein on the activation of Akt, MAPK, and caspase-3 in HT-22 cells. The cells were treated with Tat-NQO1 protein and then exposed to H~2~O~2~ as described in the "Materials and methods" section. The activation of Akt, MAPK, and caspase-3 levels was measured by Western blotting and band intensity was measured by densitometer. \*\*P \< 0.01, compared with H~2~O~2~-treated cells.](bmb-49-617f3){#f3-bmb-49-617}

![Effects of transduced Tat-NQO1 protein in an animal model of ischemia. Gerbils were treated with a single injection of Tat-NQO1 protein (2 mg/kg) before ischemia-reperfusion, and sacrificed after 7 days. Transduced Tat-NQO1 protein was analyzed by immunostaining, using anti-Histidine and DAPI staining. Ischemic neuronal damage was analyzed by NeuN-immunostaining (A). Neuronal cell viability was analyzed by Cresyl violet (CV), F-JB, Iba-1 and GFAP immunostaining. Relative numeric analysis of CV and F-JB, Iba-1, GFAP positive neurons in the CA1 region (B). Scale bar = 18.8 and 50 μm. \*\*P \< 0.01, significantly different from the vehicle group.](bmb-49-617f4){#f4-bmb-49-617}
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